ENvue Medical (FEED) Free Cash Flow Growth (3y) (2017 - 2026)
ENvue Medical (FEED) Free Cash Flow Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.90 Bn | 193.29 Bn | 7.27 Bn | 41.96% |
| 2 | Stryker | 129.12 Bn | 125.64 Bn | 4.50 Bn | 25.48% |
| 3 | Medtronic | 119.32 Bn | 110.10 Bn | 6.41 Bn | 0.05% |
| 4 | Boston Scientific | 73.63 Bn | 73.09 Bn | 3.85 Bn | 35.42% |
| 5 | Edwards Lifesciences | 52.14 Bn | 47.89 Bn | 1.35 Bn | 250.09% |
| 6 | Dexcom | 34.48 Bn | 32.54 Bn | 830.00 Mn | 12.01% |
| 7 | GE HealthCare Technologies | 34.06 Bn | 31.95 Bn | 2.18 Bn | 35.65% |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 20.87% |
| 9 | Steris | 23.17 Bn | 22.69 Bn | 684.20 Mn | 9.23% |
| 10 | ENvue Medical | 2.52 Mn | 1.38 Mn | -266,000.00 | -30.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -30.29% |
| Mar 31, 2026 | -53.33% |
| Dec 31, 2025 | -26.60% |
| Sep 30, 2025 | -0.54% |
| Jun 30, 2025 | -19.22% |
| Mar 31, 2025 | 8.17% |
| Dec 31, 2024 | 14.05% |
| Sep 30, 2024 | -9.60% |
| Jun 30, 2024 | 33.83% |
| Mar 31, 2024 | 15.34% |
| Dec 31, 2023 | 28.05% |
| Sep 30, 2023 | 0.63% |
| Jun 30, 2023 | -36.52% |
| Mar 31, 2023 | -10.30% |
| Dec 31, 2022 | -8.82% |
| Sep 30, 2022 | -20.88% |
| Jun 30, 2022 | -36.15% |
| Mar 31, 2022 | -22.94% |
| Dec 31, 2021 | 0.69% |
| Sep 30, 2021 | 7.41% |